- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
Nantero named by Scientific American as a Business Leader within the "Scientific American 50"
Shareholders of Harris & Harris Group, Inc., may be
interested to know that Nantero, Inc., has been
named by Scientific American magazine as a Business Leader within
the "Scientific American 50" -- the magazine's annual list
recognizing outstanding acts of leadership in science and technology
from the past year. Nantero has been named Business Leader in the
Nanotechnology and Molecular Electronics category because of work
over the last year in developing nonvolatile random access memory
using nanotechnology and becoming the first company to use carbon
nanotubes in a mass production semiconductor fab. The December
issue of Scientific American, in which this list appears, will be on
the newsstands on November 23, 2004. The complete list may also be
accessed on the magazine's website at www.sciam.com.
Harris & Harris Group, Inc., has invested $813,000 in privately held Nantero, Inc. Nantero is a nanotechnology company using carbon nanotubes for the development of next-generation semiconductor devices. Nantero's main focus is the development of NRAMTM a high density nonvolatile random access storage device.
Harris & Harris Group is a publicly traded venture capital company that now makes initial investments exclusively in tiny technology, including nanotechnology, microsystems and microelectromechanical systems (MEMS). The Company's last 17 initial private equity investments have been in tiny-technology enabled companies. The Company has 17,248,845 common shares outstanding.
Detailed information about Harris & Harris Group, Inc. and its holdings can be found on its website at www.TinyTechVC.com.
This news release may contain statements of a forward-looking nature relating to future events. These forward-looking statements are subject to the inherent uncertainties in predicting future results and conditions. These statements reflect the Company's current beliefs, and a number of important factors could cause actual results to differ materially from those expressed in this news release. Please see the Company's Annual Report on Form 10-K filed with the Securities and Exchange Commission for a more detailed discussion of the risks and uncertainties associated with the Company's business, including but not limited to the risks and uncertainties associated with venture capital investing and other significant factors that could affect the Company's actual results. Except as otherwise required by Federal securities laws, Harris & Harris Group, Inc., undertakes no obligation to update or revise these forward-looking statements to reflect new events or uncertainties.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
|Related News Press|
Harris & Harris Group Sponsors NYC American Heart Association's Health Sciences Innovation Investment Forum: Co-founder of Harris & Harris Group Portfolio Company TARA Biosystems to Speak About the Value of Tissue Engineering Technology April 21st, 2015
Long Island Capital Alliance Announces Participants for Brookhaven National Laboratory Technology Transfer Capital Forum on May 8: Keynote Speaker Dr. Doon Gibbs, Director of Brookhaven National Laboratory April 16th, 2015
Graphenea embarks on a new era April 16th, 2015